Back to Companies
Bicara Therapeutics Inc.
BCAXNasdaqCIK: 0002023658
Over the 50 most recent insider filings, Bicara Therapeutics Inc. (BCAX) has seen activity from 15 distinct insiders — 1 buying and 5 selling. The activity is net selling: $4.8M bought versus $10.0M sold, net sales of $5.2M. Cohlhepp Ryan (President and COO, Director) is the most active by dollar volume, and the single largest transaction was $5.0M by Cohlhepp Ryan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$34.7M
Purchases
$4.8M
Sales
$10.0M
Unique Insiders
15
Recent Insider Trades
50 loaded
| Jul 29 | BCAX Bicara Therapeutics Inc. | Oliger Christy J. | Director | Other | $0 |
| Jul 29 | BCAX Bicara Therapeutics Inc. | Bender Jeremy | Director | Other | $0 |
| Jul 29 | BCAX Bicara Therapeutics Inc. | Bender Jeremy | Director | Award | $1.0M |
| Jul 29 | BCAX Bicara Therapeutics Inc. | Oliger Christy J. | Director | Award | $1.0M |
| Jul 14 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $284.2K |
| Jul 10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $807.7K |
| Jul 10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $833.1K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | Haviland Kate | Director | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | POWELL MICHAEL | Director | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | Bowden Christopher | Director | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | Simson Jake | Director | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | Mazumdar-Shaw Kiran | Director | Award | $400.4K |
| Jun 10 | BCAX Bicara Therapeutics Inc. | Robertson Scott M. | Director | Award | $400.4K |
| May 26 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $187.9K |
| May 12 | BCAX Bicara Therapeutics Inc. | Schelman William | Chief Medical Officer | Award | $1.9M |
| Apr 28 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Sell | $125.8K |
| Apr 22 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $211.6K |
| Apr 20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $354.1K |
| Apr 17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $287.6K |
| Mar 26 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Sell | $104.2K |
| Mar 24 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $170.3K |
| Mar 20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $282.4K |
| Mar 17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $245.7K |
| Mar 5 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Sell | $305.6K |
| Mar 5 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $301.0K |
| Mar 5 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $315.9K |
| Mar 2 | BCAX Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $4.8M |
| Feb 27 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $65.5K |
| Feb 4 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Award | $2.1M |
| Feb 4 | BCAX Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | Award | $1.5M |
| Feb 4 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Award | $5.0M |
| Jan 26 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $69.3K |
| Jan 26 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $34.2K |
| Jan 20 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $2.7K |
| Dec 29 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Exercise | $221.8K |
| Dec 29 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Exercise | $150.0K |
| Dec 18 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Exercise | $321.8K |
| Dec 16 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $233.5K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $776.4K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Sell | $205.1K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $341.1K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $225.6K |
| Oct 16 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $226.9K |
| Oct 15 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $466.9K |
| Oct 10 | BCAX Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | Sell | $405.9K |
| Oct 10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $116.9K |
| Oct 8 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $553.2K |
| Oct 8 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO, Director | Sell | $911.8K |
| Oct 1 | BCAX Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | Sell | $498.7K |
50 filings+